$KMDA Announces Withdrawal of European MAA for Inhaled Alpha-1 Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease $KMDA EMA does not view the data submitted as sufficient for approval of MAA, and that data needed for approval requires an additional trial